Our Offerings

We specialize in cutting-edge biologics development to help our partners bring life-saving therapies to patients faster and more efficiently. Our expertise spans antibody drug conjugates (ADCs) and bioconjugate development, bioprocess development, analytical and formulation development services.

From conjugation optimization to preclinical material generation, we deliver scalable, robust processes with deep analytical support to move you confidently toward IND readiness.

Comprehensive biologics development support. We integrate protein engineering, process development and optimization for efficient scale-up and technology transfer.

We provide advanced analytical, formulation services and stability testing to support the comprehensive evaluation of  biologics and bioconjugates. 

End-to-end GMP manufacturing capabilities from cell banking, antibody production, purification, bioconjugation and bulk drug substance.

Xcellon leverages advanced analytics and machine learning to enhance process understanding, troubleshoot issues, and improve development efficiency.

Partner
With Us

Partner With Us

Xcellon Biologics is backed by successful biotech entrepreneurs and professionals from top pharmaceutical and CDMO companies including Lonza, Abzena, Amgen, MedImmune, AstraZeneca, BioNTech, Seattle Genetics, and Immunomedics.

We collaborate with leading innovators and global partners to accelerate biopharmaceutical breakthroughs while maintaining the highest quality and regulatory standards.